Clinical Trials Directory

Trials / Unknown

UnknownNCT04234711

Sutureless Technique and Conventional Repairs for Total Anomalous Pulmonary Venous Connection

Sutureless Technique and Conventional Repairs for Total Anomalous Pulmonary Venous Connection: an Observational Study by Chinese Heart Centers

Status
Unknown
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Guangdong Provincial People's Hospital · Academic / Other
Sex
All
Age
1 Year
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the efficacy of conventional repair and sutureless surgical repair of total anomalous pulmonary venous connection.

Detailed description

An observational, non-randomized multi-center study is proposed to compare the efficacy between conventional repair and sutureless technique for total anomalous pulmonary venous connection. Subjects will be enrolled at Guangdong Provincial People's Hospital (GPPH) and three to five participating hospitals. All clinical interventions will follow the participating hospital's standard of care. Informed consent will be obtained from all study participants before study enrollment. After undergoing their surgical repairs, study participants will be followed up at 1, 3, 6 and 12 months after initial surgery and annually thereafter. All preoperative and postoperative medical records data will be submitted to a centralized database at GPPH through a secure online research platform. Baseline and post-operative (6 months) assessments will include a history and physical examination, a quality of life survey, physical examinations, liver and kidney function assessments, serum brain natriuretic peptide (BNP), echocardiography and electrocardiography. Besides, a small amount of common pulmonary vein tissue may be required for hematein and eosin staining.

Conditions

Interventions

TypeNameDescription
PROCEDURESurgical strategyTo compare the efficacy between conventional repair and sutureless technique for total anomalous pulmonary venous connection

Timeline

Start date
2020-02-20
Primary completion
2021-08-31
Completion
2022-02-01
First posted
2020-01-21
Last updated
2020-02-11

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04234711. Inclusion in this directory is not an endorsement.